GWM
NTLA icon

GK Wealth Management’s Intellia Therapeutics NTLA Stock Holding History

GK Wealth Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.43K Buy
+450
New +$5.63K ﹤0.01% 1033

Other funds holding NTLA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GK Wealth Management's NTLA Position: Q3 2026 in Review

GK Wealth Management opened a new position in Intellia Therapeutics (NTLA) in Q3 2026: 450 shares worth $5.43K. The stake represents ﹤0.01% of the portfolio and ranks #1033 among its holdings.

6 funds tracked by Wall St. Rank hold NTLA as of Q3 2026.

  • GK Wealth Management held 450 shares of Intellia Therapeutics worth $5.43K as of Q3 2026.
  • Intellia Therapeutics was a new GK Wealth Management position in Q3 2026.
  • Intellia Therapeutics made up ﹤0.01% of GK Wealth Management's portfolio in Q3 2026, its #1033 holding.
  • 6 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.